Klinische Studie

Fareon Open Label Device Clinical Trial

NCT: NCT07600320 · NOT_YET_RECRUITING

NCT-IDNCT07600320

Medizinische Daten: StatusNOT_YET_RECRUITING

Startdatum2026-05-01

Abschluss2027-04-30

SponsorIcahn School of Medicine at Mount Sinai (OTHER)

First posted2026-05-20

Last updated2026-05-20

Kurzzusammenfassung

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.